Yuehua Li, MD
Hospitalist · Cupertino
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 32
- 9 carriers
- Offices
- 2
Offices
2 locations · Quantum Bay Area Hospitalist Medical Group Inc · 60 clinicians in this group
Looking this up.
Hospitals listed: 557754 · El Camino Health. That is not proof they admit you there this week.
Plans that list them
32 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Li’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
32 of 32 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| AARP Medicare Advantage from UHC CA-10 (HMO-POS) | UnitedHealthcare | Listed, may be out of date | Jun 10, 2026 |
California Medical Board record
Licence A164863 · Current
Licensed to practise in California · since 2019 · expires 2027-08-31 · Medical College of Wuhan University of Science and Technology.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$28,751
Medicare paid this office $28,751 for 114 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 40 | $8,629 | $97 |
| Short return visit (20+ min) | 31 | $4,173 | $80 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 22 | $3,452 | $157 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $3,104 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,803 | $106 |
See all 6 services
| Return visit (30+ min) | 40 | $8,629 | $97 |
| Short return visit (20+ min) | 31 | $4,173 | $80 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 22 | $3,452 | $157 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $3,104 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,803 | $106 |
| Hospital discharge day management, more than 30 minutes | 15 | $1,464 | $98 |
Who their Medicare patients are
114 Original Medicare patients in 2024. Average age 74 · Women 54% · Also on Medicaid 28% · Health risk score 1.78. At or below the middle of the specialty; the typical hospitalist clinician is at 2.49.
Conditions among them: High blood pressure 74% · Diabetes 39% · Coronary heart disease 34% · Chronic kidney disease 25% · Atrial fibrillation 25% · Heart failure 24% · Depression 23% · COPD 19% · Cancer 18% · Dementia 15% · Stroke 10%.
The office billed $100,221, Medicare allowed $39,301 and paid $28,751; for 320 services of 25 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 114 | 320 | 74 | 1.78 | $100,221 | $28,751 |
| 2023 | 117 | 303 | 77 | 2.17 | $110,160 | $30,384 |
| 2022 | 92 | 177 | 76 | 2.44 | $77,371 | $18,133 |
| 2021 | 157 | 413 | 72 | 2.55 | $94,160 | $27,578 |
| 2020 | 94 | 243 | 72 | 2.14 | $41,044 | $14,804 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Return visit (30+ min) | 35 | $8,891 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 42 | $5,062 | $71 |
| New patient visit (45+ min) | 32 | $4,025 | $126 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $2,787 | $107 |
| Hospital discharge day management, more than 30 minutes | 19 | $1,988 | $105 |
| Short return visit (20+ min) | 19 | $1,602 | $80 |
2022: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $5,853 | $93 |
| Return visit (30+ min) | 14 | $2,340 | $111 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,195 | $183 |
| New patient visit (45+ min) | 19 | $2,092 | $110 |
| Hospital discharge day management, more than 30 minutes | 21 | $2,064 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,090 | $64 |
2021: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 78 | $10,824 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 37 | $5,117 | $88 |
| Hospital discharge day management, more than 30 minutes | 53 | $4,625 | $86 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 20 | $1,490 | $30 |
2020: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 66 | $7,916 | $57 |
| Hospital discharge day management, more than 30 minutes | 28 | $2,460 | $88 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $1,068 | $32 |
Medicaid work
$7,576 in 2021
Medicaid paid $7,576 for 183 billed services this clinician did in 2021, up to 21 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 168 | $6,767 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 15 | $809 |
| 2021 | 183 | 2 | 21 | $7,576 |
| 2020 | 82 | 1 | 21 | $4,707 |
See the largest Medicaid services in earlier years
2020
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 82 | $4,707 |
Drugs they prescribed that Part D paid
$41,490
Pharmacies billed $41,490 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
542 generic and 55 brand-name prescriptions · $41,490 in drug cost · 40 antibiotic prescriptions to 22 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vascepa | 12 | $5,013 | $418 |
| Atorvastatin | 82 | $424 | $5 |
| Levothyroxine | 20 | $371 | $19 |
| Rosuvastatin | 20 | $371 | $19 |
| Potassium Chloride | 13 | $234 | $18 |
See all 16 drugs
| Vascepa | 12 | $5,013 | $418 |
| Atorvastatin | 82 | $424 | $5 |
| Levothyroxine | 20 | $371 | $19 |
| Rosuvastatin | 20 | $371 | $19 |
| Potassium Chloride | 13 | $234 | $18 |
| Hydralazine | 13 | $219 | $17 |
| Chlorthalidone | 12 | $199 | $17 |
| Amlodipine Besylate | 40 | $194 | $5 |
| Losartan | 36 | $183 | $5 |
| Metoprolol | 13 | $116 | $9 |
| Clopidogrel | 15 | $112 | $7 |
| Escitalopram | 13 | $104 | $8 |
| Metformin | 23 | $88 | $4 |
| Atenolol | 19 | $54 | $3 |
| Cephalexin | 12 | $43 | $4 |
| Azithromycin | 14 | $14 | $1 |
Year by year
| 2024 | 597 | 82 | None | 9% | $41,490 |
| 2023 | 568 | 78 | None | None | $42,267 |
| 2022 | 410 | 105 | None | None | $30,533 |
| 2021 | 231 | 86 | None | None | $9,437 |
| 2020 | 158 | 47 | None | None | $7,976 |
| 2019 | 373 | 60 | 0% (0) | 11% | $20,288 |
| 2018 | 491 | 79 | None | None | $26,529 |
| 2017 | 186 | 38 | None | None | $7,116 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Ozempic | 11 | $12,643 | $1,149 |
| Eliquis | 11 | $6,391 | $581 |
| Atorvastatin | 72 | $809 | $11 |
| Metformin | 30 | $552 | $18 |
| Levothyroxine | 13 | $366 | $28 |
| Losartan | 28 | $285 | $10 |
| Glimepiride | 12 | $263 | $22 |
| Amlodipine Besylate | 29 | $193 | $7 |
| Cephalexin | 19 | $166 | $9 |
| Chlorthalidone | 11 | $109 | $10 |
| Levetiracetam | 11 | $100 | $9 |
| Metoprolol | 21 | $96 | $5 |
| Clopidogrel | 16 | $77 | $5 |
| Zolpidem | 13 | $29 | $2 |
2022: 8 drugs
| Eliquis | 12 | $6,287 | $524 |
| Atorvastatin | 29 | $252 | $9 |
| Metformin | 23 | $190 | $8 |
| Losartan | 20 | $184 | $9 |
| Amlodipine Besylate | 27 | $151 | $6 |
| Metoprolol | 27 | $120 | $4 |
| Levofloxacin | 11 | $53 | $5 |
| Furosemide | 14 | $42 | $3 |
2021: 2 drugs
| Atorvastatin | 12 | $179 | $15 |
| Metoprolol | 14 | $70 | $5 |
2020: 2 drugs
| Atorvastatin | 15 | $68 | $5 |
| Amlodipine Besylate | 14 | $38 | $3 |
2019: 9 drugs
| Atorvastatin | 53 | $501 | $9 |
| Metoprolol | 12 | $217 | $18 |
| Famotidine | 13 | $173 | $13 |
| Amlodipine Besylate | 34 | $143 | $4 |
| Losartan | 12 | $89 | $7 |
| Tamsulosin | 18 | $77 | $4 |
| Metformin | 16 | $75 | $5 |
| Hydrochlorothiazide | 13 | $73 | $6 |
| Warfarin | 13 | $59 | $5 |
2018: 11 drugs
| Simvastatin | 12 | $441 | $37 |
| Atorvastatin | 46 | $302 | $7 |
| Metoprolol | 16 | $248 | $15 |
| Amlodipine Besylate | 40 | $132 | $3 |
| Tamsulosin | 14 | $118 | $8 |
| Omeprazole | 14 | $99 | $7 |
| Losartan | 16 | $98 | $6 |
| Pantoprazole | 16 | $89 | $6 |
| Metformin | 15 | $54 | $4 |
| Lisinopril | 20 | $52 | $3 |
| Metoprolol | 16 | $50 | $3 |
2017: 2 drugs
| Atorvastatin | 17 | $144 | $8 |
| Amlodipine Besylate | 12 | $26 | $2 |
Money from drug and device companies
$147 in 2025
| 2025 | 2 | 2 | None | $147 |
| 2024 | 2 | 2 | None | $159 |
| 2023 | 2 | 2 | None | $108 |
| 2022 | 1 | 1 | None | $91 |
| 2021 | 1 | 1 | None | $125 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Mayne Pharma Commercial | Bijuva | $122 | 1 payment
|
| Revance Therapeutics | None | $26 | 1 payment
|
See all 2 published payments
| Mayne Pharma Commercial | Meals · 2025-08-20 | Bijuva | $122 |
| Revance Therapeutics | Meals · 2025-02-06 | None | $26 |
See earlier years (2024, 2023, 2022, 2021)
2024: $159
| Gilead Sciences | Vemlidy | $125 | 1 payment
|
| Regeneron Healthcare Solutions | Eylea | $34 | 1 payment
|
2023: $108
| Medtronic | Percept PC Brainsense | $91 | 1 payment
|
| Sanofi Pasteur | Fluzone Quadrivalent Northern Hemisphere | $16 | 1 payment
|
2022: $91
| GlaxoSmithKline | Trelegy Ellipta | $91 | 1 payment
|
2021: $125
| Allergan | None | $125 | 1 payment
|
Professional record
- NPI
- 1265960108
- Licence
- CA A164863, NV 20032California A164863: Current · expires 2027-08-31
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X); Hospitalist (208M00000X)
- Mailing address
- 13055 La Vista Dr, Saratoga, CA, 95070
- NPI first listed
- 2017-05-23
- NPI last updated
- 2021-08-11
- NPI record certified
- 2021-06-30
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 27200 Calaroga Ave, Hayward, CA, 94545